Evidence map›Paper›PMID 40604765›Full record

ArticleBMC health services research2025

Drug utilization pattern among type II diabetic patients in Palestine.

Murad Abualhasan, Mai Awad, Waleed Sweileh

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Murad AbualhasanFaculty of Pharmacy, An-Najah National University, P.O. Box 7, Nablus, State of Palestine. m_abualhasan@najah.edu.
Mai AwadFaculty of Pharmacy, An-Najah National University, P.O. Box 7, Nablus, State of Palestine.
Waleed SweilehDepartment of Physiology and Pharmacology/Toxicology, Division of Biomedical Sciences, College of Medicine and Health Sciences, An-Najah National University, P.O. Box 7, Nablus, State of Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus is a common metabolic disorder marked by hyperglycemia. Studying the use of anti-diabetic medications is essential for promoting proper drug use and improving healthcare planning.

objectiveThis study aims to examine the drug utilization patterns and prescribing practices among Type 2 Diabetic Patients in Palestine. Specifically, it seeks to identify the most commonly prescribed medications, evaluate adherence to clinical guidelines, and assess factors influencing drug utilization at diabetes healthcare centers operated by the Ministry of Health (MOH) in Palestine.

methodsA cross-sectional survey was conducted among 400 randomly selected patients with T2DM attending diabetic clinics in the northern and central regions of the West Bank, Palestine. Data on prescribing patterns and medication adherence were collected through patient interviews, and ethical guidelines were strictly followed throughout the study.

resultsThe study found that metformin was the most frequently prescribed initial therapy for patients with T2DM. Medication adherence was notably high, with 68% of patients consistently taking their medications as directed, although 24% reported occasionally forgetting to do so. Approximately 90% of patients followed the prescribed dosage exactly as instructed. There were no statistically significant differences in metformin prescribing patterns across the regions; prescriptions for glimepiride varied significantly (p = 0.01). Combination therapies were also commonly used.

conclusionThis research can enhance our understanding of diabetes treatment methods, patient adherence, and the factors influencing prescription decisions. Ultimately, this will support the development of more effective strategies for diabetes management.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsPractice Patterns, Physicians'AdultAgedCross-Sectional StudiesFemaleHumansMaleMetforminMiddle AgedMiddle EastHypoglycemic AgentsMetforminDrug utilization reviewHyperglycemiaOral hypoglycemic agentsType 2 diabetes mellitus

Identifiers

PMID40604765
PMCPMC12225167

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.